📄 genetic and genomic medicine

Investigating the Y chromosome in complex disease: Phenome-wide scan across 104,334 Finnish men

This study conducted a phenome-wide association study in over 104,000 Finnish men to investigate Y-chromosomal variation in complex diseases, identifying a significant link between haplogroup I1 and coronary heart disease despite finding no other phenome-wide significant associations.

Original authors: Preussner, A., Leinonen, J. T., FinnGen,, Liu, A., Pirinen, M., Tukiainen, T.

Published 2026-06-17

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Preussner, A., Leinonen, J. T., FinnGen,, Liu, A., Pirinen, M., Tukiainen, T.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

The Big Picture: The "Forgotten Cousin" of Our DNA

Imagine your DNA is a massive library containing the instruction manual for building and running a human body. Most of the books in this library are read by both men and women. However, there is one very small, unique book called the Y chromosome. It only exists in men, and it's tiny—about the size of a pamphlet compared to the encyclopedia-sized books (autosomes) that make up the rest of the library.

For a long time, scientists studying disease have mostly ignored this tiny pamphlet. They thought it was only important for deciding if a baby is a boy or for making sperm. This study decided to finally dust off that pamphlet and read it closely to see if it holds any other secrets about men's health.

The Experiment: A Massive Search Party

The researchers used a huge database called FinnGen, which contains health and genetic data from over 104,000 Finnish men.

The Map: They looked at the "Y chromosome pamphlet" and identified different family branches, called haplogroups. Think of these like different family surnames passed down from father to son. In Finland, the most common "surnames" (haplogroups) were N1a1, I1, R1a, and R1b.
The Search: They checked if men with specific "surnames" were more likely to have any of 1,426 different health conditions, ranging from heart disease and diabetes to allergies and back pain.

The Challenge: The "Geography Trap"

There was a big problem. The Y chromosome doesn't mix and match like other DNA; it stays the same from father to son. This means that certain "surnames" (haplogroups) are often stuck in specific towns or regions.

The Analogy: Imagine you find that everyone in a specific village has a rare eye color. If you also find that everyone in that same village has a higher rate of a specific disease, is it the eye color causing the disease? Or is it the fact that they all live in the same village, eat the same food, and breathe the same air?
The Fix: The researchers had to be very careful to make sure they weren't just finding patterns caused by geography. They used advanced math to adjust for where people were born and lived, ensuring they were looking at the DNA, not just the neighborhood.

The Results: A Few Clues, But No Smoking Gun

After running the massive search, the results were a bit mixed:

No "Grand Slam" Hits: They didn't find any single Y-chromosome link that was statistically undeniable (like a slam dunk). The evidence wasn't strong enough to say, "This DNA definitely causes this disease" with 100% certainty.
The "Suggestive" Clues: They found 121 hints (called "suggestive associations"). These weren't proof, but they were interesting enough to investigate further.
The "Kin Test" (The Lie Detector): To see which hints were real, they used a clever trick. They looked at the brothers and sisters of the men in the study.
- The Logic: Brothers share the same Y chromosome. Sisters do not. If a disease is truly caused by the Y chromosome, the "risk" should show up in the brothers but disappear in the sisters.
- The Winner: Out of all the hints, only one passed this test convincingly: Haplogroup I1 (a specific family branch) seemed to be linked to a slightly higher risk of Coronary Heart Disease (CHD).

The Star Discovery: The I1 Heart Connection

The paper focuses heavily on the link between the I1 family branch and heart disease.

The Mystery: Previous studies in the UK suggested this link, but critics said it was just because I1 men lived in areas with more heart disease (the "Geography Trap" again).
The Finnish Proof: In Finland, the I1 family is actually more common in the Southwest, while heart disease is more common in the Northeast. Since the "bad" DNA and the "bad" heart disease areas didn't overlap, the researchers could rule out geography as the cause.
The Conclusion: Even after checking for smoking, other genetic risks, and even the loss of Y chromosomes in blood cells (a known risk factor), the link remained. It suggests that carrying the I1 "surname" might make a man's heart slightly more vulnerable, perhaps due to how his genes regulate the body.

Why Didn't They Find More?

The paper admits that their tools were a bit blunt.

The Low-Resolution Map: The genetic "map" they used was like a low-resolution photo. It could see the big family branches (like I1 or N1a1), but it couldn't see the tiny details or specific mutations within those branches.
The Missing Pieces: Because the Y chromosome is so tricky to read with standard tools, they likely missed many subtle variations. The paper argues that we need better, more detailed maps of the Y chromosome to find the rest of the clues.

The Bottom Line

This study is like a detective who finally decided to investigate a suspect everyone else ignored. While they didn't solve the whole case, they found a very strong lead: The Y chromosome, specifically the I1 family branch, likely plays a small but real role in a man's risk of heart disease.

The researchers conclude that we need to stop ignoring this tiny part of our DNA. If we want to fully understand why men get sick, we need to read the "pamphlet" more carefully and with better tools.

Problem Statement
Despite representing approximately 2% of the male genome, the Y chromosome is frequently excluded from genome-wide association studies (GWAS) due to its unique genomic architecture. Challenges include a lack of recombination across most of the chromosome, leading to strong correlations between variants and pronounced population stratification; its haploid nature, which complicates allele dosage modeling; and the restriction of analyses to male samples, which limits statistical power. Consequently, while somatic loss of the Y chromosome (LOY) has been linked to various male health outcomes, the contribution of inherited (germline) Y-chromosomal variation to complex diseases remains poorly understood and underexplored in large-scale biobank data.

Methodology
The authors conducted a phenome-wide association study (PheWAS) using data from the FinnGen project, comprising 104,334 unrelated Finnish men.

Data Processing: From an initial set of 554 Y-chromosomal markers on the FinnGen custom array, quality control yielded 60 common variants (minor allele frequency ≥ 1%). These variants were used to define nine distinct haplogroup clades: I1, N1a1, R1a, R1b, IJ, K, P1, I1a2-Z73, and R1a-Z284.
Phenotypes: The study analyzed associations between these haplogroups and 1,426 traits, including 1,413 binary clinical endpoints and 13 quantitative traits.
Statistical Analysis: Associations were tested using REGENIE, with specific adjustments for the haploid nature of the Y chromosome (doubling effect sizes and standard errors derived from diploid coding). Models were adjusted for age, genotyping batch, principal components (1-20), and birth region to control for population stratification.
Validation Strategy: To distinguish true Y-chromosomal effects from confounding factors (such as geography or shared environment), the authors employed a kin-based validation design. They compared effect sizes from the main PheWAS against associations observed in the phenotypes of first-degree male relatives (positive control, sharing the Y chromosome) and first-degree female relatives (negative control, not sharing the Y chromosome).
Confounding Checks: Specific attention was paid to the association between haplogroup I1 and coronary heart disease (CHD), given previous conflicting reports. The authors stratified analyses by geographical region, adjusted for CHD polygenic risk scores (PRS), smoking status, and LOY status.

Key Results

PheWAS Findings: Using a conservative phenome-wide significance threshold ( $p < 3.9 \times 10^{-6}$ ), no statistically significant associations were identified. However, using a suggestive threshold ( $p < 5.6 \times 10^{-3}$ ), 121 associations were observed across various disease categories.
Kin-Based Validation: Of the 121 suggestive associations, 38 (32%) were supported by kin-based validation, showing concordant effects in male relatives and null effects in female relatives.
Haplogroup I1 and CHD: The study found a suggestive association between haplogroup I1 and coronary heart disease (OR=1.06, 95% CI=1.02-1.11, $p=3.7 \times 10^{-3}$ ). This association was supported in the kin-based validation (male validation OR=1.05; female validation OR=0.97). Crucially, the I1-CHD association remained consistent across distinct geographical regions within Finland, was independent of autosomal CHD risk (PRS), and was not explained by smoking or LOY status.
Other Associations: Haplogroup R1b showed suggestive associations with colorectal neoplasms, which were also supported by kin-based validation. Haplogroup N1a1, the most frequent in Finland, showed the fewest suggestive associations, with a trend toward risk-decreasing effects.
Genomic Resolution: The study noted that the standard genotyping array captured only a fraction of the Y-chromosomal diversity in Finland, missing 98 out of 100 known sublineages, highlighting limitations in current variant capture for this population.
Coding Variation: Analysis of whole-exome sequencing data revealed that haplogroup N1a1 carriers had fewer protein-altering variants compared to other haplogroups. While no specific causal variant was confirmed for the I1-CHD link, a gene-level enrichment for missense variants in KDM5D was observed in I1 carriers.

Significance and Claims
The paper claims to provide the first comprehensive phenome-wide analysis of Y-chromosomal associations in a large biobank cohort, specifically including the N1a1 haplogroup. The authors assert that their findings:

Support a Germline Link to Heart Disease: They provide evidence supporting a link between germline Y-chromosomal variation (specifically haplogroup I1) and coronary heart disease risk, independent of population stratification, autosomal risk, and somatic LOY.
Validate Methodological Approaches: The study demonstrates that kin-based validation is a robust method for confirming Y-chromosomal associations and filtering out confounding signals.
Highlight Data Limitations: The results emphasize that current genotyping arrays are insufficient for capturing the full spectrum of Y-chromosomal diversity in specific populations, necessitating improved variant capture and deeper sequencing for future studies.
Call for Inclusion: The authors conclude that the Y chromosome should be systematically included in large-scale genetic studies to better understand the male-specific genetic architecture of complex diseases, noting that the absence of genome-wide significant hits in this study should not be interpreted as evidence against biologically meaningful effects due to the conservative nature of multiple-testing corrections applied to highly correlated haplotypes.